Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2603

Feb 4, 2016

Are you covered? Emerging issues for health care providers under cyber risk insurance

Posted by in categories: biotech/medical, health, law, policy, security

Tough to be a doctor these days — Could be bad news for Providers with limited or no Cyber Risk Coverage.


Providers are focusing on cybersecurity with increased urgency. Cyberattacks on health-care organizations reached an all-time high in 2015 and aren’t expected to slow down in 2016, Harry Greenspun, director for Deloitte’s Center for Health Solutions, told Bloomberg BNA. One element of a comprehensive strategy to address data security is customized cyber risk insurance. Recent case law supports standing for class action litigants alleging future injuries, which may not be covered by some policy forms. We urge providers to review their cyber risk coverage with the increasing risks and this new case law in mind.

Specifically, it is critical that cyber risk insurance is designed to both: adequately mitigate future harm to those whose private information is compromised as a result of a data breach; and satisfy the full array of damages sought by such third parties, including damages for future injuries resulting from the anticipated improper use of data. These considerations are increasingly important because the policies available in today’s market are not standardized. While many absorb some of the costs associated with notification and fraud monitoring, existing forms may not protect against damages sought for susceptibility to identity theft.

Continue reading “Are you covered? Emerging issues for health care providers under cyber risk insurance” »

Feb 4, 2016

Graphene Brain Implants May Help Patients Regain Sensory Functions And Control Motor Disorders

Posted by in categories: biotech/medical, computing, materials, neuroscience

Graphene; the material for brain chip implants; however, Q-Dots ferrofluid is where it will make us totally rethink brain implants in the future.


A new technology developed by researchers in Italy and the United Kingdom allows for the creation of graphene-based materials that can be interfaced with neurons without losing its electrical conductivity. This can lead to the creation of neural electrodes that are not only biocompatible, but stable within the body as well. (Photo : University of Cambridge)

Scientists from the United Kingdom and Italy have developed a new process in which a carbon form known as graphene is combined with neurons without sacrificing the integrity of these cells.

Continue reading “Graphene Brain Implants May Help Patients Regain Sensory Functions And Control Motor Disorders” »

Feb 4, 2016

Scientists have extended the lifespan of mice

Posted by in categories: biotech/medical, health, life extension

A new study has shown that the lifespans of mice can be extended by up to 35 percent by simply clearing out senescent cells — defunct cells that stop dividing, accumulate in old age, and trigger inflammation in fat, muscle, and kidney tissues.

Not only did the mice experience significantly longer lifespans thanks to removal of these cells, but the treatment also delayed the onset of age-related disorders such as heart and kidney deterioration, and the development of cataracts and tumours.

“It’s not just that we’re making these mice live longer; they actually stay healthier longer too. That’s important, because if you were going to equate this to people, well, you don’t want to just extend the years of life that people are miserable or hospitalised,” one of the team, cell biologist Darren Barker from the Mayo Clinic College of Medicine, told William Herkewitz at Popular Mechanics.

Read more

Feb 4, 2016

Nootropic Drug Can Reverse And Prevent Cognitive Decline In Rats

Posted by in categories: biotech/medical, life extension, neuroscience

Ampakines are known mental stimulants, but in rats they can also shelter the brain from age-related decline and even reverse deterioriation

A number of changes happen in the aging brain and one of these is a dendritic loss which onsets around middle age. In a new study, researchers have shown a particular drug belonging to the ampakine class of compounds, has significant neuroprotective properties.

Shielding the brain

Continue reading “Nootropic Drug Can Reverse And Prevent Cognitive Decline In Rats” »

Feb 4, 2016

Do Computer Scientists Hold the Key to Treating Cancer?

Posted by in categories: biotech/medical, computing

2016-01-29-1454078214-8291223-Patterson_cancer.jpg
By David Patterson Professor of Computer Science University of California, Berkeley This ancient assassin, first identified by a pharaoh’s physician, has been killing people for more than 4,600 years. As scientists found therapies for other lethal diseases–such as measles, influenza, and heart disease–cancer moved up this deadly list and will soon be #1; 40% of Americans will face cancer during their lifetimes, with half dying from it. Most of us ignore cancer until someone close is diagnosed, but instead society could zero in on this killer by recording massive data to discover better treatments before a loved one is in its crosshairs.

Cancer is unlimited cell growth caused by problems in DNA. Some people are born with precarious DNA, and others acquire it later. When a cell divides, sometimes it miscopies a small amount of its DNA, and these errors can overwhelm a cell’s defenses to cause cancer. Thus, you can get it without exposure to carcinogens. Cigarettes, radiation, asbestos, and so on simply increase the copy error rate. Speaking figuratively, every time a cell reproduces, we roll the dice on cancer, with such mutagens loading the dice to raise cancer’s chances.

Most cancer studies today use partial genomic information and have fewer than 1,000 patients. One wonders whether their conclusions would still hold if they used complete genomes and increased the number of patients by factors of 10–100.

Read more

Feb 3, 2016

Can Your DNA Determine If You’re a Morning Person or Night Owl?

Posted by in categories: biotech/medical, genetics, neuroscience

New study identifies genetic variants associated with preference to mornings or nights.

Read more

Feb 2, 2016

Opportunities in Cancer Nanotechnology: A Conversation with NCI’s Dr. Piotr Grodzinski

Posted by in categories: biotech/medical, nanotechnology

Wonderful article on Nanotechnology and cancer with NCI’s Dr. Piotr Grodzinski. NCI established NCI’s with NCI’s Dr. Piotr Grodzinski. The article was published by declara.


Learn about Opportunities in Cancer Nanotechnology: A Conversation with NCI’s Dr. Piotr Grodzinski. Declara makes it easy to discover, share and organize knowledge. We empower individuals, organizations and countries to develop the knowledge needed to solve big problems.

Read more

Feb 2, 2016

Robot drills electrodes into British teen’s brain, cures epilepsy

Posted by in categories: biotech/medical, neuroscience, robotics/AI, transportation

A British teenager has become the first child in the UK to be cured of epilepsy by a robot that drilled deep into his brain.

Billy Whitaker, 15, had suffered daily seizures for seven years until the operation two weeks ago, which medical experts are convinced has cured him.

The procedure used a £350,000 ($503,455) robot, practically the same as those used on car factory production lines, to drill electrodes into Whitaker’s brain.

Read more

Feb 2, 2016

Mexico may be the next frontier for medical marijuana

Posted by in category: biotech/medical

Could Mexico become the new Amsterdam for US and Canadian tourists?


Marijuana investors are looking at Mexico as a potentially sizable market.

Read more

Feb 2, 2016

2,000 year old ‘computer’ discovered: How tech and shipwrecks are rewriting human history

Posted by in categories: 3D printing, biotech/medical, computing

Researchers are only steps away from bioprinting tissues and organs to solve a myriad of injuries and illnesses. TechRepublic has the inside story of the new product accelerating the process.

If you want to understand how close the medical community is to a quantum leap forward in 3D bioprinting, then you need to look at the work that one intern is doing this summer at the University of Louisville.

Read more